Tarsus to Participate in Upcoming Investor Conferences [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Tarsus Pharmaceuticals, Inc. (TARS)
Company Research
Source: Yahoo! Finance
proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that management will participate in the following conferences: William Blair Growth Stock Conference Jeff Farrow, Chief Financial and Chief Strategy Officer, will participate in an in-person fireside chat on Tuesday, June 4, 2024, at 1:20 p.m. PT / 4:20 p.m. ET Jefferies Global Healthcare Conference Jeff Farrow, Chief Financial and Chief Strategy Officer, and Aziz Mottiwala, Chief Commercial Officer, will participate in an in-person fireside chat on Wednesday, June 5, 2024, at 12 p.m. PT / 3 p.m. ET Goldman Sachs Global Healthcare Conference Bobak Azamian, M.D., Ph.D., Chief Executive Officer and Chairman, and Jeff Farrow, Chief Financial and Chief Strategy Officer, will participate in an in-person fireside chat on Monday, June 10, 2024, at 11 a.m. PT / 2 p.m. ET Live webcasts and additional information about the webcasts can be accessed on the events sectio
Show less
Read more
Impact Snapshot
Event Time:
TARS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TARS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TARS alerts
High impacting Tarsus Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
TARS
News
- InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs [Forbes]Forbes
- Tarsus to Participate in Upcoming Investor ConferencesGlobeNewswire
- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at HC Wainwright from $57.00 to $61.00. They now have a "buy" rating on the stock.MarketBeat
- Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]Yahoo! Finance
- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Barclays PLC from $50.00 to $60.00. They now have an "overweight" rating on the stock.MarketBeat
TARS
Earnings
- 5/8/24 - Beat
TARS
Sec Filings
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- TARS's page on the SEC website